Current Cancer Drug Targets

Home

Home
FOR AUTHORS
ARTICLES
SUBSCRIBERS & CORPORATES
CONTENTS & ABSTRACTS
CONTACT US

Thursday, May 18, 2017

Home » »

4:41 AM No comments

New Issue Published Current Cancer Drug Targets Vol 17 issue 5

Email This BlogThis!Share to X Share to Facebook

Related Posts:

Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles … Read More
Call For Paper Call For Paper … Read More
Free Trial Offer Free Trial Offer … Read More
Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies … Read More
New Issue Published Current Cancer Drug Targets Vol 17 issue 7 New Issue Published Current Cancer Drug Targets Vol 17 issue 7 … Read More

← Newer Post Older Post → Home

0 comments:

Post a Comment

Social Profiles

Blogroll

Popular
Tags
Blog Archives

New Issue Published Current Cancer Drug Targets Vol 18 issue 3

New Issue Published Current Cancer Drug Targets Vol 18 issue 3
New Issue Published Current Cancer Drug Targets Vol 17 issue 9

New Issue Published Current Cancer Drug Targets Vol 17 issue 9
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Author(s): Otília Menyhart, Libero Santarpia and Balazs GyorffyPages 665-683 (19) Abstract: The introduction of trastuzumab for anti-H...
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives

Author(s): Rena Chiotaki, Hara Polioudaki and Panayiotis A. TheodoropoulosPages 256-269 (14) Abstract: Breast cancer stem cells (BCSCs...
Free Trial Offer

Free Trial Offer
Call For Paper

Call For Paper
Free Trial Request

Free Trial Request
Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets

Indian Authors have made substantial contributions to Bentham Science Journal Current Cancer Drug Targets Journal Name: Current Canc...
Most Accessed Article Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Most Accessed Article : Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Call For Paper

Call For Paper

Blog Archive

► 2018 (3)
- ► April (1)
- ► February (1)
- ► January (1)

▼ 2017 (36)
- ► December (1)
- ► October (4)
- ► September (1)
- ► August (4)
- ► July (4)
- ► June (2)
- ▼ May (4)
- ► April (3)
- ► March (4)
- ► February (3)
- ► January (6)

► 2016 (24)
- ► December (6)
- ► November (4)
- ► October (8)
- ► August (1)
- ► June (5)

BTemplates.com

Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives

Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo

Pleiotropic Role of HSF1 in Neoplastic Transformation

Blogroll

About

Copyright © 2025 Current Cancer Drug Targets | Powered by Blogger

Design by FThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | NewBloggerThemes.com